The aim has been to find a recipe for improving diabetes control and weight loss, and again GLP-1 turns out to be involved
While semaglutide isnt directly linked to an increased risk, elevated blood sugar levels in those taking the medication could contribute to a higher risk of developing genital yeast infections, particularly in susceptible individuals
(PubMed) Wu P, Ma J, Yang S, et al
Coverage for obesity indications (Wegovy, Saxenda, Zepbound) remains more limited
With ongoing support and healthy habits, many patients sustain their weight loss over the long term
S7F), while pyroglutamate presented decreased concentration (Fig